45
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Analysis of somatic mutations provides insight into the mutational processes that have shaped the cancer genome, but such analysis currently requires large cohorts. We develop deconstructSigs, which allows the identification of mutational signatures within a single tumor sample.

          Results

          Application of deconstructSigs identifies samples with DNA repair deficiencies and reveals distinct and dynamic mutational processes molding the cancer genome in esophageal adenocarcinoma compared to squamous cell carcinomas.

          Conclusions

          deconstructSigs confers the ability to define mutational processes driven by environmental exposures, DNA repair abnormalities, and mutagenic processes in individual tumors with implications for precision cancer medicine.

          Electronic supplementary material

          The online version of this article (doi:10.1186/s13059-016-0893-4) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: not found

          Signatures of mutational processes in human cancer

          All cancers are caused by somatic mutations. However, understanding of the biological processes generating these mutations is limited. The catalogue of somatic mutations from a cancer genome bears the signatures of the mutational processes that have been operative. Here, we analysed 4,938,362 mutations from 7,042 cancers and extracted more than 20 distinct mutational signatures. Some are present in many cancer types, notably a signature attributed to the APOBEC family of cytidine deaminases, whereas others are confined to a single class. Certain signatures are associated with age of the patient at cancer diagnosis, known mutagenic exposures or defects in DNA maintenance, but many are of cryptic origin. In addition to these genome-wide mutational signatures, hypermutation localized to small genomic regions, kataegis, is found in many cancer types. The results reveal the diversity of mutational processes underlying the development of cancer with potential implications for understanding of cancer etiology, prevention and therapy.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Reshaping Data with thereshapePackage

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Microsatellite instability in colorectal cancer.

              Microsatellite instability (MSI) is a hypermutable phenotype caused by the loss of DNA mismatch repair activity. MSI is detected in about 15% of all colorectal cancers; 3% are of these are associated with Lynch syndrome and the other 12% are caused by sporadic, acquired hypermethylation of the promoter of the MLH1 gene, which occurs in tumors with the CpG island methylator phenotype. Colorectal tumors with MSI have distinctive features, including a tendency to arise in the proximal colon, lymphocytic infiltrate, and a poorly differentiated, mucinous or signet ring appearance. They have a slightly better prognosis than colorectal tumors without MSI and do not have the same response to chemotherapeutics. Discovery of MSI in colorectal tumors has increased awareness of the diversity of colorectal cancers and implications for specialized management of patients.
                Bookmark

                Author and article information

                Contributors
                javier.herrero@ucl.ac.uk
                taylorb@mskcc.org
                charles.swanton@crick.ac.uk
                Journal
                Genome Biol
                Genome Biol
                Genome Biology
                BioMed Central (London )
                1474-7596
                1474-760X
                22 February 2016
                22 February 2016
                2016
                : 17
                : 31
                Affiliations
                [ ]UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, Paul O’Gorman Building, Huntley Street, London, WC1E 6DD UK
                [ ]The Francis Crick Institute, 44 Lincoln’s Inn Fields, London, WC2A 3LY UK
                [ ]Centre for Mathematics and Physics in the Life Sciences and Experimental Biology (CoMPLEX), University College London, London, WC1E 6BT UK
                [ ]UCL Cancer Institute, Bill Lyons Informatics Centre, Paul O’Gorman Building, Huntley Street, London, WC1E 6DD UK
                [ ]Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY USA
                [ ]Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY USA
                [ ]Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY USA
                Article
                893
                10.1186/s13059-016-0893-4
                4762164
                26899170
                d6f10631-0789-493e-b675-e9145f428c70
                © Rosenthal et al. 2016

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 30 October 2015
                : 4 February 2016
                Funding
                Funded by: FundRef http://dx.doi.org/http://dx.doi.org/10.13039/501100000781, European Research Council;
                Funded by: FundRef http://dx.doi.org/http://dx.doi.org/10.13039/501100000833, Rosetrees Trust;
                Funded by: FundRef http://dx.doi.org/http://dx.doi.org/10.13039/501100000265, Medical Research Council;
                Funded by: Cancer Research United Kingdom
                Funded by: FundRef http://dx.doi.org/10.13039/501100000329, Novo Nordisk UK Research Foundation;
                Award ID: 16584
                Award Recipient :
                Categories
                Software
                Custom metadata
                © The Author(s) 2016

                Genetics
                mutational signatures,esophageal carcinoma,apobec,single samples
                Genetics
                mutational signatures, esophageal carcinoma, apobec, single samples

                Comments

                Comment on this article